Fig. 4
From: Immune landscape of the tumour microenvironment in Ethiopian breast cancer patients
Association of the immune phenotypes with the patients’ survival. A: Kaplan-Meier survival curves between IP4 versus IP2 and IP3. Patients were followed for 60 months and survival probabilities were determined by calculating p values from log rank test. B-G: Kaplan-Meier survival curves derived from TCGA data set of 177 African American BC cases. B: Survival probabilities across the four IPS. C: HR + BC survival within the four IPs. D: HR- BC survival within the four IPs. E: survival between the two IP groups F: HR- BC survival within the two IP groups. G: HR + BC survival within the two IP groups. IP1 & IP2 were categorized as “Immune Activated” while IP3 and IP4 were categorized as “Immune Suppressed”